From Name:
From Email:
To Name:
To Email:

Optional Message:


Actinic keratosis treatment approved

from Pharmacy Times

The FDA has approved Biofrontera's topical prescription drug BF-200 ALA and medical device BF-RhodoLED. The products may be used for photodynamic therapy treatment of mild to moderate actinic keratosis on the face and scalp. Actinic keratosis is characterized by lesions (often on the face, scalp, lips, arms, and hands) caused by frequent exposure to the sun's ultraviolet rays. Patients with actinic keratosis may develop rough, scaly patches of skin. If left untreated, this may develop into squamous cell carcinoma. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063